Hims & Hers Health (HIMS) Receivables - Net (2020 - 2026)
Hims & Hers Health (HIMS) reported Receivables - Net of $149.6 million for Q1 2026, up 365.4% sequentially from $32.1 million in Q4 2025.
Hims & Hers Health (HIMS) Receivables - Net (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Receivables - Net data on file, last reported at $149.6 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net changed N/A year-over-year to $149.6 million; the trailing twelve-month figure through Mar 2026 stood at $149.6 million (changed N/A YoY), and the FY2025 full-year result was $32.1 million, up 427.03% from the prior year.
- Receivables - Net improved to $149.6 million in Q1 2026, from $32.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $149.6 million in Q1 2026 to a low of $3.9 million in Q4 2022.
- A 5-year average of $39.7 million and a median of $6.7 million in 2023 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net retreated 8.96% in 2024 and surged 427.03% in 2025, its largest moves.
- Tracing HIMS's Receivables - Net over 5 years: stood at $3.9 million in 2022, then surged by 71.79% to $6.7 million in 2023, then dropped by 8.96% to $6.1 million in 2024, then surged by 427.03% to $32.1 million in 2025, then soared by 365.4% to $149.6 million in 2026.
- Business Quant data shows HIMS's Receivables - Net at $149.6 million in Q1 2026, $32.1 million in Q4 2025, and $6.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.62 Mn |
| Mar 31, 2026 | 149.62 Mn |
| Dec 31, 2025 | 32.15 Mn |
| Dec 31, 2025 | 32.15 Mn |
| Dec 31, 2024 | 6.10 Mn |
| Dec 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | 6.70 Mn |
| Dec 31, 2023 | 6.70 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 4.10 Mn |
| Dec 31, 2021 | 4.10 Mn |
| Dec 31, 2020 | 1.10 Mn |
| Dec 31, 2020 | 1.10 Mn |